2015
DOI: 10.1111/crj.12352
|View full text |Cite
|
Sign up to set email alerts
|

Synchronous mantle cell lymph node lymphoma and pulmonary adenocarcinoma: a case report with literature review

Abstract: Progresses are necessary to understand the pathogenesis of of synchronous occurrence of both diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 11 publications
(10 reference statements)
0
10
0
Order By: Relevance
“…Coexistence of adenocarcinoma and mantle cell lymph node lymphoma in other anatomical sites, such as lung, has been reported in literature. Braham et al 13 presented the first case of primary lung adenocarcinoma associated to lymph node MCL. This lymphoma is usually synchronously present with plasma cell dyscrasia or granulomatous diseases such as sarcoidosis 14,15 .…”
Section: Discussionmentioning
confidence: 99%
“…Coexistence of adenocarcinoma and mantle cell lymph node lymphoma in other anatomical sites, such as lung, has been reported in literature. Braham et al 13 presented the first case of primary lung adenocarcinoma associated to lymph node MCL. This lymphoma is usually synchronously present with plasma cell dyscrasia or granulomatous diseases such as sarcoidosis 14,15 .…”
Section: Discussionmentioning
confidence: 99%
“…[275,276] One of the most accepted theories about the synergy between one neoplasm and another is the secondary chronic inflammatory process that solid neoplasms generate can trigger lymphoma. [35,90] Chronic inflammatory processes such as infections (H. Pylori, Epstein-Barr, HIV, and hepatitis C) or autoimmune diseases (chronic thyroiditis, Sjogren's syndrome, celiac disease, and rheumatoid arthritis) are known to be associated with the development of B-cell lymphoma, mainly MALT type lymphoma. [277,278] The mechanisms for this lymphoid transformation are not clear.…”
Section: Discussionmentioning
confidence: 99%
“…In the literature, a total of 6 cases with synchronous MCL and lung carcinoma were reported, and all of them received chemotherapy (18,(32)(33)(34)(35)(36) (Table II). Specifically, Kampalath et al (18) reported that a rare case of synchronous MCLBMI and ES-SCLC was treated with cisplatin, etoposide and rituximab, and remained in complete remission for ~2.5 years following the initial diagnosis.…”
Section: Discussionmentioning
confidence: 99%